Global Liver Institute Thanks Senator Bill Cassidy for His Leadership in Fatty Liver Disease ResearchU.S. Agency for Healthcare Research and Quality to Assess True Prevalence and Impact of...
We extend our deepest gratitude to Dr. Jennifer Guy, Dr. Anjana Pillai, Dr. Christopher Rose, Dr. Elliot Tapper, patient advocate Bruce Dimming, and our sponsors. In case you missed it, our webinar...
Global Liver Institute Statement on the Passing of Dr. Stephen HarrisonThe entire field of liver health has experienced an incredible loss. It is with great sadness that Global Liver Institute, our...
Addressing Disparities in Organ Transplantation: A Call for Equitable Healthcare Introduction Organ transplantation has revolutionized modern medicine, offering a beacon of hope for individuals...
Congress begins Fiscal Year 2025 appropriations process and the Administration approves new treatments improving the lives of liver disease patients. Join Global Liver Institute to Push Congress to...
New App Helps Predict Pediatric Transplant Need Celebrating the repurposed use of Livmarli for pediatric rare liver disease patients Global Liver Institute (GLI) celebrates a major...
The U.S. FDA approves Madrigal Pharmaceuticals Rezdiffra™ (resmetirom) as the FIRST NASH therapeutic option in the U.S. This breakthrough follows years of NASH patient-led multi-stakeholder...
White House declares April 2024 as Cancer Prevention and Early Detection Month This landmark announcement from the White House follows ongoing advocacy efforts, including a letter to President Joe...
Healthy Eating, Healthy Liver: The Links Between Nutrition and Liver Wellness Maintaining optimal liver health is crucial, given the liver's pivotal role as a major detoxifying organ. The...
GLI Commends Repurposed Livmarli’s FDA Approval for Patients over 5 with PFIC(Washington, D.C. March 14, 2024) –Global Liver Institute (GLI) celebrates a win for rare disease patients with the...
Recent News
Congress begins Fiscal Year 2025 appropriations process and the Administration approves new treatments improving the lives of liver disease patients. Join Global Liver Institute to Push Congress to Advance Priority Bills and Support Agency Efforts.In the post-election...
New App Helps Predict Pediatric Transplant Need Upcoming Pediatric and Rare Liver Diseases Council Semi-Annual Meeting Our upcoming council meeting is scheduled for May 8, 2024. We're thrilled to welcome Alex Betourne, PhD, PharmD, the Scientific...
Providing Access to Rezdiffra for NASH and the Therapies to Come | AMCP 2024 At the Academy of Managed Care Pharmacy meeting on April 16, experts discussed the emerging landscape of NASH treatments, focusing on the recent approval of Madrigal’s Rezdiffra. Donna...
Global Liver Institute Thanks Senator Bill Cassidy for His Leadership in Fatty Liver Disease ResearchU.S. Agency for Healthcare Research and Quality to Assess True Prevalence and Impact of NAFLD/MASLD(Washington, D.C., May 1, 2024) – GLI applauds the announcement of a...
We extend our deepest gratitude to Dr. Jennifer Guy, Dr. Anjana Pillai, Dr. Christopher Rose, Dr. Elliot Tapper, patient advocate Bruce Dimming, and our sponsors. In case you missed it, our webinar ‘Liver Cancer Care: Management of Hepatic Encephalopathy, Ascites, and...
